AstraZeneca PLC - Operating Expenses

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Operating-Expenses" stands at 31.93 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

AstraZeneca PLC's third quarter result of 8.75 Billion USD for the item "Operating Expenses" represents an increase of 14.29 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 8.75 Billion USD for the item "Operating Expenses" represents an increase of 23.92 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of 31.93 Billion USD for the item "Operating Expenses" represents an increase of 5.58 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.66 percent compared to the value the year prior.
The 1 year change in percent is 14.66.
The 3 year change in percent is 38.38.
The 5 year change in percent is 96.69.
The 10 year change in percent is 84.87.

The Serie's long term average value is 18.79 Billion United States Dollars. It's latest available value, on 09/30/2025, is 69.95 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2017, to it's latest available value, on 09/30/2025, is +134.95%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.